Multiple Myeloma: Is it time to rethink how we sequence treatments?

  • calender Friday, February 13th, 2026
  • clock 18:00h - 19:30h UTC

Prof. Karthik Ramasamy

Prof. Karthik Ramasamy
Hematologist

Oxford University Hospitals NHS Trust

United Kingdom
More information

Dr Joshua Richter

Dr Joshua Richter
Hematologist

Icahn School of Medicine at Mount Sinai

United States
More information

Dr ​Faisal Basheer

Dr ​Faisal Basheer
Hematologist

Cambridge University Hospitals NHS Trust

United Kingdom
More information

Dr Andrew Charlton

Dr Andrew Charlton
Hematologist

Newcastle Upon Tyne Hospitals NHS Trust

United Kingdom
More information

A virtual Experts Knowledge Share on the topic of ‘Is it time to rethink how we sequence treatment in multiple myeloma?’, with Scientific Committee Prof. Karthik Ramasamy (Oxford, UK), Dr Joshua Richter (Mount Sinai, US), Dr Faisal Basheer (Cambridge, UK) and Dr Andrew Charlton (Newcastle, UK) 

 Topics of conversation include: 

  • ​​Myeloma bench to bedside: considerations at each line of therapy 
  • Every move matters: rethinking sequencing strategies in modern myeloma 
  • Clinical studies to clinical reality: patient case studies discussion

This event has been sponsored by Menarini Stemline and is intended for HCPs in the UK only

Please submit any questions regarding sequencing of treatment that you wish the panel to address to selina.gill@cor2ed.com by 9th January

endorsement
Endorsement

This event has been sponsored by Menarini Stemline and is intended for HCPs in the UK only.

Other events of your interest

SLEEP CONNECT cme
The Role of PARPi in Prostate Cancer: Experts Knowledge Share

This Experts Knowledge Share meeting is chaired by an internationally renowned faculty in order to discuss the role of PARPi in prostate cancer.

This Experts Knowledge Share is hosted by COR2ED. AstraZeneca has provided a sponsorship grant towards this independent programme

Stay tuned for new events

Keep updated!